Remeditex Ventures

Total investments

17

Average round size

24M

Portfolio companies

10

Rounds per year

1.31

Lead investments

4

Follow on index

0.41

Exits

7

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyBeautyHealth CareHealth DiagnosticsGeneticsMedical DeviceDeveloper PlatformLife SciencePharmaceuticalTherapeutics

Summary

The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Dallas.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Remeditex Ventures, startups are often financed by Boulder Ventures, Amgen Ventures, Broadview Ventures. The meaningful sponsors for the fund in investment in the same round are Atlas Venture, Boulder Ventures, Amgen Ventures. In the next rounds fund is usually obtained by Boulder Ventures, Atlas Venture, Amgen Ventures.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Health Care, Biopharma. The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Rodin Therapeutics, Bi02 Medical, Navitor Pharmaceuticals

The high activity for fund was in 2015. The fund is generally included in less than 2 deals every year. This Remeditex Ventures works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2019. The typical startup value when the investment from Remeditex Ventures is 100-500 millions dollars. The real fund results show that this VC is 8 percentage points more often commits exit comparing to other companies. Deals in the range of 10 - 50 millions dollars are the general things for fund.

Show more

Investments analytics

Analytics

Total investments
17
Lead investments
4
Exits
7
Rounds per year
1.31
Follow on index
0.41
Investments by industry
  • Health Care (14)
  • Therapeutics (12)
  • Biotechnology (11)
  • Pharmaceutical (6)
  • Medical Device (5)
  • Show 7 more
Investments by region
  • United States (17)
Peak activity year
2015

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
14
Avg. valuation at time of investment
15M
Group Appearance index
0.94
Avg. company exit year
8
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Bellicum Pharmaceuticals 07 Jan 2014 Biotechnology, Health Care, Health Diagnostics, Therapeutics Early Stage Venture 14M United States, Texas, Houston
Don't Tell My Wife Stables 22 Oct 2022 Sports, Outdoors, Racing Seed 367K United States, Texas, Fort Worth
Navitor Pharmaceuticals 18 Dec 2015 Biotechnology, Health Diagnostics, Developer Platform, Pharmaceutical, Biopharma Early Stage Venture 33M United States, Massachusetts, Cambridge
Veracity Selfcare 14 Sep 2021 Health Care Seed 5M
VINN Automotive Technologies 01 Oct 2019 Automotive, E-Commerce, Internet Seed British Columbia, Victoria, Canada

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.